Long-term results of aortic valve replacement in elderly and senile patients
Authors:
Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation
For correspondence: Sign in or register.
Type: Original articles
DOI:
For citation: Chabaidze T.A., Muratov R.M., Sigaev I.Yu., Keren M.A., Kazumyan B.V., Akbutaeva G.M., Kudashev I.F. Long- term results of aortic valve replacement in elderly and senile patients. Creative Cardiology. 2025; 19 (2): 208–216 (in Russ.). DOI: 10.24022/1997-3187-2025-19-2-208-216
Received / Accepted: 10.02.2025 / 22.04.2025
Keywords: aortic stenosis mechanical prostheses biological prostheses risk factors
Abstract
Objective. To study the long-term results of aortic valve replacement in elderly and senile patients, depending on the type of implantable prosthesis (mechanical or biological), with an assessment of risk factors for long-term mortality.
Material and methods. A retrospective analysis of 205 elderly and senile patients (average age – 77 years (Q1–Q3: 74–84), min – 64 years, max – 96 years) who underwent prosthetics in the period from 2005 to 2015 was carried out. The patients were divided into 2 groups depending on the type of implanted prosthesis: MP (mechanical prosthesis) (n=111) and BP (biological prosthesis) (n=94). The results of the interventions were evaluated over a period of 1 to 10 years, with a median follow-up of 5.00 [3.00; 8.00].
Results. The type of prosthesis did not affect long-term survival. The overall long-term mortality was 6.83% (n=14) with no significant differences between the groups (p=0.658). When analyzing the predictors of long-term mortality, the independent risk factors were: Charlson comorbidity index, baseline risk level according to EuroSCORE II, history of myocardial infarction (MI), atrial fibrillation (AF), chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) of functional class IV according to NYHA. When comparing the frequency of valve-dependent non-fatal complications and anticoagulant-dependent non-fatal complications in the studied groups, it was revealed that the group with MP was more likely to experience major bleeding compared with the PD group (5.7% vs. 0%, in MP and PD, respectively, p=0.033), in the group with PD – degeneration The valve was observed in 4.7% of patients (0% versus 4.7% in MP and PD, respectively, p=0.040). During the study follow-up period, the frequency of AK reprosthetics was 6.7% (n=7) in the MP group and 9.3% (n=8) in the PD group (p=0.593).
Conclusion. Implantation of MP and PD during prosthetics of AK in elderly and senile patients demonstrated the same safety profile: the overall long-term mortality during the follow-up period did not differ. Minimizing the risk of anticoagulant- dependent complications remains a priority in elderly patients, which makes PD preferable. Younger patients have a higher long-term survival rate when using MP, despite the risk of bleeding. The decision to choose the type of prosthesis requires an individual assessment of comorbidity and consideration of the patient’s readiness for lifelong anticoagulant therapy.
References
- Prendergast B., Vahanian A. The 2021 ESC/EACTS guidelines for the management of valvular heart disease: a new template for Heart Teams and their patients. Cardiovasc. Res. 2022; 118 (1): e11–e13. DOI: 10.1093/cvr/cvab362
- Caus T., Chabry Y., Nader J., Fusellier J.F., De Brux J.L. Trends in SAVR with biological vs. mechanical valves in middle-aged patients: results from a French large multi-centric survey. Front. Cardiovasc. Med. 2023; 10: 1205770. DOI: 10.3389/fcvm.2023.1205770
- Kvaratskhelia G.G., Asymbekova E.U., Golubev E.P., Khinchagov D.Ya., Akhmedov M.B. Long-term results of coronary artery bypass grafting in patients with minimal and moderate aortic valve stenosis. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2024; 66 (6): 810–816 (in Russ.). DOI: 10.24022/0236-2791-2024-66-6-810-816
- Jiang Y., Wang S., Bian J., Chen S., Shao Y. Mechanical versus bioprosthetic aortic valve replacement in middle-aged adults: a systematic review and meta-analysis. J. Cardiovasc. Dev. Dis. 2023; 10 (2): 90. DOI: 10.3390/jcdd10020090
- Skopin I.I., Otarov A.M. Preoperative risk factors in aortic valve replacement in elderly and senile patients. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2017; 18 (3): 243–255 (in Russ.). DOI: 10.24022/1810-0694-2017-18-3-243-255
- Golukhova E.Z. Report on the scientific and therapeutic work of the Bakulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation for 2023 and development prospects. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2024; 25 (Special Issue): 5–141 (in Russ.). DOI: 10.24022/1810-0694-2024-25
- Diaz R., Hernandez-Vaquero D., Alvarez-Cabo R., Avanzas P., Silva J. Long-term outcomes of mechanical versus biological aortic valve prosthesis: Systematic review and meta-analysis. J. Thorac. Cardiovasc. Surg. 2019; 158 (3): 706–714.e18. DOI: 10.1016/j.jtcvs.2018.10.146
- Chan J., Narayan P., Fudulu D.P., Dong T., Vohra H.A., Long-term clinical outcomes in patients between the age of 50-70 years receiving biological versus mechanical aortic valve prostheses. Eur. J. Cardiothorac. Surg. 2025; 67 (2): ezaf033. DOI: 10.1093/ejcts/ezaf033
- Kim H.J., Kim J.B., Jung S.H., Choo S.J. Prosthesis-patient mismatch after surgical aortic valve replacement in patients with aortic stenosis. Interact. Cardiovasc. Thorac. Surg. 2020; 31 (2): 152–157. DOI: 10.1093/icvts/ivaa085
- Kadyraliev B.K., Belov V.A., Harutyunyan V.B., Marchenko A.V., Kadyralieva N.V. Immediate and medium-term results of aortic valve replacement with a biological prosthesis in elderly patients: the experience of one center. Perm Medical Journal. 2023; 40 (6): 61–73 (in Russ.). DOI: 10.17816/pmj40661-73
- Chabaidze T.A., Muratov R.M., Sigaev I.Yu., Keren M.A., Zhelikhazheva M.V. The use of mechanical and biological prostheses in the position of the aortic valve in elderly and senile patients: immediate results. Creative Cardiology. 2024; 18 (3): 362–373 (in Russ.). DOI: 10.24022/1997-3187-2024-18-3-362-373
- Coisne A., Lancellotti P., Habib G., Garbi M., Sanchez Dahl J., Barbanti M. et al. ACC/AHA and ESC/EACTS Guidelines for the management of valvular heart diseases: JACC Guideline Comparison. JACC. 2023; 82 (8) 721–734. DOI: 10.1016/j.jacc.2023.05.061
- Klimenko A.A., Andriyashkina D.Yu., Karpova N.Yu., Kondrashov A.A. Patient management with aortic stenosis: what is new in the 2023 clinical guidelines? Russian Medical Journal. 2024; 3: 2–6 (in Russ.).
- Huckaby L.V., Sultan I., Gleason T.G., Chen S., Thoma F. Outcomes of tissue versus mechanical aortic valve replacement in patients 50 to 70 years of age. J. Card. Surg. 2020; 35: 2589–2597. DOI: 10.1111/jocs.14844
- Vogt F., Santarpino G., Fujita B., Frerker C., Bauer T. Surgical aortic valve replacement in patients aged 50–69 years-insights from the German Aortic Valve Registry (GARY). Eur. J. Cardiothorac. Surg. 2022; 62: ezac286.
- Chiang Y.P., Chikwe J., Moskowitz A.J., Itagaki S., Adams D.H. Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years. JAMA. 2014; 312: 1323–1329.
- Alex S., Hiebert B., Arora R., Menkis A., Shah P. Survival and long-term outcomes of aortic valve replacement in patients aged 55 to 65 years. Thorac. Cardiovasc. Surg. 2017; 66: 313–321.
- Babenko S.I., Soboleva N.N., Bakuleva N.P., Titov D.A., Muratov R.M. Long-term results of implantation of xenopericardial prostheses “Biolab” in the position of valves of the left chambers of the heart. Complex Problems of Cardiovascular Diseases. 2018; 7 (2): 61–70 (in Russ.). DOI: 10.17802/2306-1278-2018-7-2-61-70
- Babenko S.I., Titov D.A., Sachkov A.S., Amiragov R.I. Medical and scientific work of the Department of Emergency surgery of acquired heart defects in 2023. Bulletin of the A.N. Bakulev National Research Center of the Russian Academy of Medical Sciences. Cardiovascular Diseases. 2024; 25 (5): 515–521 (in Russ.).
- Kakabaev D.B., Skopin I.I., Kakhktsyan P.V., Otarov A.M., Slivneva I.V. Surgical revascularization of the myocardium as a factor in optimizing treatment outcomes for heart valve diseases in elderly patients. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2019; 20 (9–10): 790–798 (in Russ.). DOI: 10.24022/1810-0694-2019-20-9-10-790-798
- Muratov R.M., Babenko S.I. The bicuspid aortic valve: prospects for surgical treatment. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2023; 65 (3): 254–268. DOI: 10.24022/0236-2791-2023-65-3-254-268
- Cappabianca G., Ferrarese S., Musazzi A., Terrieri F., Corazzari C. Predictive factors of long-term survival in the octogenarian undergoing surgical aortic valve replacement: 12-year single centre follow up. Heart Vessels. 2016; 31 (11): 1798–1805. DOI: 10.1007/s00380-016-0804-3
- Resnik E.V., Smirnova A.S., Dzhobava E.M., Puzenko D.V., Smirnov A.P. Long-term results of aortic valve replacement: a clinical observation. Russian Medical Journal. Medical Review. 2023; 4: 28–32 (in Russ.).
- Ortensi L., Vitali T., Mirra R., Ortensi M., Borromeo C. Ageing-oriented prosthetic treatment plan: a case report. Prosthesis. 2023; 5: 496–508. DOI: 10.3390/prosthesis5020034
- Babeshko C.C., Barbuhatti K.O., Shumkov D.I., Kaleda V.I. Predictors of adverse outcomes in the early and long-term after aortic valve replacement in patients with severe systolic dysfunction of the left ventricle. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2024; 66 (2): 166–177 (in Russ.). DOI: 10.24022/0236-2791-2024-66-2-166-177
About Authors
- Tamara A. Chabaidze, Cardiologist; ORCID
- Ravil M. Muratov, Dr. Med. Sci., Professor, Head of Department, Cardiovascular Surgeon; ORCID
- Igor Yu. Sigaev, Dr. Med. Sci., Professor, Head of Department, Cardiovascular Surgeon; ORCID
- Milena A. Keren, Dr. Med. Sci., Professor of Chair, Senior Researcher, Cardiologist; ORCID
- Bagrat V. Kazumyan, Cand. Med. Sci., Cardiovascular Surgeon; ORCID
- Gulrukh M. Akbutayeva, Ultrasonic Diagnostician; ORCID
- Igor F. Kudashev, Cardiovascular Surgeon; ORCID